BiotechTube
Home/Noema Pharma/Dr. Luigi Costa
DL

Dr. Luigi Costa

Chief Executive Officer

Noema Pharma

Therapeutic Areas

NeurologyNeuropsychiatry

Noema Pharma Pipeline

DrugIndicationPhase
NOE-101 (basimglurant)Trigeminal NeuralgiaPhase 2b
NOE-105 (dipraglurant)Isolated DystoniaPhase 2b
NOE-115Binge Eating DisorderPhase 2